Wednesday 28 October 2020: Bermuda Hospitals Board (BHB) today announces that Dr Christopher Fosker has been appointed to the position of Director of Oncology at BHB, taking over from Dr Sein Aung. Dr Aung will continue at BHB as a Consultant Oncologist.
As Director of Oncology, Dr Fosker will be the medical lead for cancer services at BHB. His responsibilities will include consulting with cancer patients in Bermuda and managing their care, working with healthcare partners here and overseas and developing cancer services on-island. He reports to the Chief of Medicine, Dr Michael Ashton.
Dr Chris Fosker joined Bermuda Hospitals Board as an Oncologist in May 2015, tasked with treating cancer patients with radiation therapy, chemotherapy and molecular therapy. Dr Fosker works also with Bermuda Cancer and Health Centre as their medical director overseeing the radiation programme. He is an affiliate medical staff member at Dana-Farber Cancer Institute and a consultant at Brigham and Women’s hospital in Boston. Prior to his arrival in Bermuda, Dr Fosker worked at St James’ Institute of Oncology in Leeds, UK. Dr Fosker has a Bachelor of Science in Genetics and graduated from Leeds Medical School in 2003. He completed a Fellowship at Princess Margaret Hospital in Toronto, where he received the RS Bush Award for academic excellence. He was also this year awarded a fellowship by the Royal College of Physicians in the UK in recognition of his excellence and commitment in the field of oncology care.
Dr Ashton comments: “I would like to congratulate Dr Fosker on his appointment. Oncology services at BHB provide a critical service to patients with cancer in Bermuda, and it is a busy department. Chemotherapy treatments increased from 3,260 in fiscal year 2016-17 to 3, 943 in 2019-20 and the service is very highly rated in our regular patient satisfaction surveys. Dr Fosker’s relationships with patients and providers in Bermuda and overseas will be of great benefit in leading this ever-evolving department. A special thank you must go to Dr Aung who has led the department for the last six years, and we are very fortunate that he is continuing with us.”
Dr Fosker adds: “I am looking forward to building on the great work in Oncology in this role. We have a great team at KEMH and we remain committed to providing the best service possible for people in our community with cancer. Although this is a new role for me, I would like to reassure my patients that I will continue to be there for them.”